Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-061667
Filing Date
2011-11-07
Accepted
2011-11-07 16:47:07
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v237454_10q.htm 10-Q 763849
2 EXHIBIT 31.1 v237454_ex31-1.htm EX-31.1 14762
3 EXHIBIT 31.2 v237454_ex31-2.htm EX-31.2 14997
4 EXHIBIT 32.1 v237454_ex32-1.htm EX-32.1 8349
  Complete submission text file 0001144204-11-061667.txt   2812835

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nvlt-20110930.xml EX-101.INS 381293
6 XBRL TAXONOMY EXTENSION SCHEMA nvlt-20110930.xsd EX-101.SCH 14562
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvlt-20110930_cal.xml EX-101.CAL 39948
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvlt-20110930_def.xml EX-101.DEF 93036
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvlt-20110930_lab.xml EX-101.LAB 93418
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvlt-20110930_pre.xml EX-101.PRE 101262
Mailing Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458
Business Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458 617-244-1616
NOVELOS THERAPEUTICS, INC. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-119366 | Film No.: 111185198
SIC: 2834 Pharmaceutical Preparations